At Diadem we have achieved a breakthrough in solving one of the largest unmet medical needs in healthcare, predicting alzheimer's accurately when there are no symptoms. We are working with the leading institutes, scientists and industry partners to bring a simple, cost effective and rapid immuno-diagnostic to the marker and enable the selection of asymptomatic patients from healhty individuals for clinical trials and treatments in development.


We have exciting developments at Diadem. The new site will be up shortly.